chrisvoncsefalvay/vaers-outcomes huggingface dataset:
postnasal drip; trouble hearing; she has some redness; soreness; swelling of lymph nodes; nausea; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of UPPER-AIRWAY COUGH SYNDROME (postnasal drip), HYPOACUSIS (trouble hearing), ERYTHEMA (she has some redness), PAIN IN EXTREMITY (soreness) and LYMPHADENOPATHY (swelling of lymph nodes) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Loratade, but patient stated that she didn't take this medication), Thyroid disorder NOS and Blood pressure.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UPPER-AIRWAY COUGH SYNDROME (postnasal drip), HYPOACUSIS (trouble hearing), ERYTHEMA (she has some redness), PAIN IN EXTREMITY (soreness), LYMPHADENOPATHY (swelling of lymph nodes), NAUSEA (nausea) and ARTHRALGIA (joint pain). The patient was treated with IBUPROFEN on 26-Feb-2021 at an unspecified dose and frequency. At the time of the report, UPPER-AIRWAY COUGH SYNDROME (postnasal drip), HYPOACUSIS (trouble hearing), ERYTHEMA (she has some redness), PAIN IN EXTREMITY (soreness), LYMPHADENOPATHY (swelling of lymph nodes), NAUSEA (nausea) and ARTHRALGIA (joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient was on concomitant medication for thyroid and blood pressure. 27-Feb-2021 she was advised to have Tylenol, victim and plenty of water.   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: outcome updated.
This spontaneous report as received from a health care professional refers to a 23 year old female patient. On 01-SEP-2009, the patient was vaccinated with her first dose of GARDASIL (concentration, dose and lot number not reported). On 01-FEB-2010, the patient received her second dose of GARDASIL (concentration, dose and lot number not reported). It was reported that the patient had not yet received her third dose of GARDASIL. The reporter stated that no adverse effects have been observed or reported. Additional information has been requested.
2 strokes on June 24th then a few days later she started having seizures.  She had 2 more strokes the same year sometime before December.  Then in January,  she had 2 more strokes.  She had 6 strokes within a 7 month period.
Pt complained of red circle under her arm, some itching. Pharmacist advised her to take BENADRYL to help relieve itching.
Presents with SOB, fatigue and headache. Covid positive.Discahrged with PO decadron.Hospitalization
sore arm; Lots of energy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (Lots of energy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (Lots of energy). At the time of the report, PAIN IN EXTREMITY (sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (Lots of energy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       She stated that her side effects were good because she could do some garden work.  No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-291002:Dose 2 case
Patient received Moderna vaccine under the age of 18 years old. Patient had no adverse reaction except for a sore arm.
Clinic received notification that the patient has tested positive for COVID-19 after being fully vaccinated.  Per the documentation in notes, he received the Jensen vaccine on 3/16.  Became symptomatic on 4/24 and was tested positive  on 4/26.   The specific lot and expiration date are not know at this time.  Was not administered during one of our  clinics.
Within 48 hours post vax, pt was hospitalized, mouth ulcers and dehydration, maybe not related but progressed to acute demyelination cerebellar encephalitis.
Patient reports TIA 24 hours after vaccination followed by stroke 10 days later. Stroke resulted in Bradycardia requiring Atropine due to pulse of 20 BPM. Clot buster TNK administered successfully
PATIENT WAS SEATING IN THE LOBBY AFTER THE IMMUNIZATION.  TEN MINUTES LATER THE PATIENT PASSED OUT. PARAMEDICS WERE CALLED AND AFTER THEIR EXAMINATION ALL VITALS ARE NORMAL, THE PATIENT WAS RELEASED AND NO ADDITIONAL MEDICAL ATTENTION WAS PROVIDED.
This spontaneous report as received from a nurse (registered nurse) refers to a patient of unknown age. The patient was inadvertently vaccinated with a dose of 0.5 ml live VARIVAX (Merck) (lot # 0025AA) SQ, on 16-JAN-2013 that had expired on 18-DEC-2012. No adverse effects reported. Additional information has been requested.
TESTED POSITIVE TWICE FOR COVID; This spontaneous report received from a patient concerned a 56 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211A21A, expiry: 14-DEC-2021) dose was not reported, administered on 13-SEP-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 01-MAR-2022, Laboratory data included: COVID-19 antigen test (NR: not provided) Twice positive. On an unspecified date, the patient experienced tested positive twice for covid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tested positive twice for covid was not reported. This report was non-serious.
One week after injection swelling,ichty ness  and warmth and redness at injection site. Started 03/19/2021 and is still there at this time 03/21/2021.
once syringe was out, the needle retracted; a drop of vaccine, dropped out; This spontaneous case was reported by a pharmacist and describes the occurrence of DEVICE CONNECTION ISSUE (once syringe was out, the needle retracted) and UNDERDOSE (a drop of vaccine, dropped out) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event were reported).    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced DEVICE CONNECTION ISSUE (once syringe was out, the needle retracted) and UNDERDOSE (a drop of vaccine, dropped out). On 29-Mar-2021, DEVICE CONNECTION ISSUE (once syringe was out, the needle retracted) and UNDERDOSE (a drop of vaccine, dropped out) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
06/10/2021 I had a rash all over my body, they are just spots that do not itch sometimes. Still happening to this day. I went to my dr office on  06/23/2021 the NP thought it was a rash due to poison ivy, prescribed prednisone and  Zyrtec , I took it until June 30th, and it was not working, dr said to stop taking it and  Dr believed it was the vaccine that attacked my eczema.  Stop taking the prednisone and gave me a different steriod shot. The bumps are still there to this day
intense headache; achiness; fever; This is a spontaneous report from a contactable consumer. A 33-year-old male patient started to receive bnt162b2, via an unspecified route of administration in the right arm from 06Jan2021 13:00 at a SINGLE DOSE for covid-19 immunization. Patient has no relevant medical history. Historical vaccine included bnt162b2 on16Dec2020 for covid-19 immunization (1st dose).  The patient's concomitant medications were not reported.  About 12 hours after 2nd dose on 07Jan2021, intense headache, achiness, and fever which lasted acutely for another 24 hours, and continues to persist moderately. Resulted in needing to take day off of work. The outcome of events was recovering. No treatment received due to events.  Information about Lot/batch number is requested.
Skin rash with some hives covering entire front and back of torso. reddened skin under arms and groin area. swelling of nose and stiff neck, inflamed throat tissue. extreme fatigue. er tx adderax, prednisone injection sent home with prednisone 40mgx5days, claritin 10mg, rash reduced but not entirely clear by third day.
given to immunocompetent 25 yo patient; Shingrix given by mistake, Varicella vaccine was intended; This case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a 25-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In April 2022, the patient received Shingrix. In April 2022, unknown after receiving Shingrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   Additional Information: GSK Receipt Date: 6-MAY-2022 Reporter's Comment: The physician reported that Shingrix was given 2 weeks prior to reporting date to a 25-year-old immunocompetent patient by mistake when Varicella vaccine was intended to be given.  The physician asked was there any safety information, timing of Varicella vaccine administration. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: A 25-year-old immunocompetent patient received Shingrix by mistake instead of Varicella vaccine, which led to inappropriate age at vaccine administration and wrong vaccine administered.
1 week after receiving my first dose, I have swelling, redness, mild discomfort, and itching in a ~4 inch diameter circle at the injection site.  Symptoms have progressed slowly throughout the day and seem to be stable though have not improved at all yet. To treat at home, I have tried ice, benadryl cream, and hydrocortisone cream which have not worked. It has been 10 hours since the symptoms began and I have not sought medical treatment since this seems like a relatively mild side effect. I have also had hives sporadically appear on my legs (upper thighs) every day since the vaccine, but they are mild too and have not needed any treatment.
Patient received 3rd dose in series, did not disclose she was vaccinated while traveling prior to receiving this dose.  She told staff it was her first COVID vaccination while it was actually her third.
Initial and follow up information has been received from a licensed practical nurse concerning a female patient who on an unknown date was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. After the patient received the vaccine, the patient experienced pain at the injection site for two days. Unspecified medical attention was sought. Subsequently, the patient recovered. No product quality complaint was involved. Additional information is not expected.
After immunizations were given, mother nursed baby for 5-6 min, he then went limp, tried to arouse could not, pt had a pulse and was breathing, interrupted physician to see pt, she did and tried to arouse and consulted another physician in practice, Dr., once he came in pt had started to open eyes, mother states this wasn't a sleeping pattern, unsure if he had a seizure or syncopal episode. Dr. consulted the NICU physician he felt no testing needs done unless it happens again, then a neuro consult would be indicated. For future we will give 1 immunization at a time.
About 10 minutes post vaccination, she felt tired, lightheaded, chest pain, and tingling in hand and throat. She states she then passed out and fell out of chair onto the floor. Her mother administered Epi pen. Ems evaluated. Pt transported to hospital ER via ambulance.
Generally healthy 73-year-old woman transferred from LRGH for weakness.  Yesterday she is tripped and fell in the bathroom landing on her tailbone sending a jarring discomfort up through her spine but she was able to feel normal walk around all day and even drive to Rhode Island and back.  When she got back she started feeling tired and she noticed when she woke up around 10 or 11:00 at night to go to the bathroom that she had weakness proximally in her upper more than lower extremities and some tingling.  She does feel a mild headache, some aching in her neck, aching in her back, and her weakness progressed to the point where she had difficulty getting up. In the emergency department she had increasing weakness, difficulty speaking and swallowing therefore she was intubated for airway protection. She underwent brain MRI with and without contrast.  She was briefly extubated on 5/16 however continued to have progressive weakness requiring reintubation.  Neurology was engaged and patient underwent lumbar puncture in interventional radiology. Patient is on ventilator 5/18/21.
booster; Caller recently got COVID19 from someone at work; there are 3 people with heart problems who have gotten booster dose of the vaccine in the same house; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 58 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 2, Pfizer Covid 19 Vaccine, Lot: EW0161, Expiry: Unknown, Right arm for both doses, not feeling good on 25Nov2021), administration date: 30Apr2021, for Covid-19 immunization, reaction(s): "not feeling good", "Tired", "Achy", "Cold"; Bnt162b2 (Dose 1, Pfizer Covid 19 Vaccine, Lot: EW0167, Expiry: Unknown, Right arm for both doses), administration date: 09Apr2021, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; EXPOSURE TO SARS-COV-2 (non-serious), outcome "unknown", described as "Caller recently got COVID19 from someone at work"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "there are 3 people with heart problems who have gotten booster dose of the vaccine in the same house".  Additional information: Specify Consumer or other non health professional: Mother. He took a test yesterday, and on the bottom line was pink and purple, and the top line was pink so that means he has Covid. States that on 23Nov2021, a 20 year old that her son works with got Covid. He notified the people at work, including her son, and since then several people and their families who have not had the vaccines have gotten Covid. Caller verifies that her son did get both doses of the vaccine but he did not have time to get the booster because he did not meet the age group requirements. Her son started having symptoms of Covid on 26Nov2021. Additional Vaccines Administered on Same Date of the Pfizer Suspect.
Mother reports child broke out in a rash within 48 hours of receiving MMR, Varicella and Hep A vaccines administered at another providers office, seen on 9/23/2014 - rash appears viral, no treatment given.
This case was reported in a literature article and described the occurrence of acute myositis in a child subject of unspecified gender who was vaccinated with Oral polio vaccine (manufacturer unspecified), DT. The present retrospective cohort study of acute flaccid paralysis was conducing using computerized diagnosis data and medical record review of potential cases among children aged 1 month to less than 15 year and diagnosed from 1 January 1992 through 31 December 1998. The subjects were hospitalized or seen in the emergency room. None of the children were known to have a preexisting immunocompromising condition. The literature article included the description of 16 children with vaccine exposure prior to development of paralytic syndrome (B0642828A, B0642829A, B0642830A, B0642832A, B0642836A, B0642841A, B0642846A, B0642847A, B0642848A, B0642849A, B0642850A, B06428511A, B0642852A, B0642853A). On an unspecified date the subject received unspecified dose of Oral polio vaccine, unspecified dose of DT vaccine. Twenty five days after vaccination with DT and Oral polio vaccine, the subject experienced acute myositis. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events was unspecified. The author considered that internationally, there are advantages to using oral polio vaccine, but the stability of vaccine-derived oral polio vaccine viruses remained a concern and importation of such neurovirulent isolateds to nonendemic areas remained an important risk.
12/3/21 - Event occurred at the school district event at School. This RN was in hallway when patient walks out and was mildly upset. RN walks with to cafeteria which is the observation area. Patient relays information to RN that she was there for Pfizer booster but was accidentally given a Moderna shot. RN walks patient to observation provider. Patient then decides she does not want to wait in cafeteria due to lots of noise and leaves to go outside. Provider asks RN to catch up with patient to get name and DOB. RN catches up to patient and speak to her outside of school.  Patient verbalized she was not upset about the wrong shot but instead that she was upset because she was nervous about the safety of the event. Patient had tears in eyes and relayed to RN that she also has cancer and anxiety and was having a hard day already. She thanks RN for speaking with her. Patient says she will go home to relax and calm down.  At the time of entering this incident, does not show that the vaccine has been entered yet nor which nurse gave the vaccine.  No adverse reactions occurred but it was a vaccine administration error which is why this RN is reporting it.
Pt states he received flu shot 11/29/01 and then experienced decreased strength and flexibility in left arm about 2 wks post vaccine. Did not consult MD. Was in MUA 02/25/02 with resulting injury to chest and face. Has been doing weight lifting to strengthen arms and strength has improved but still c/o decreased flexibility.
1 hour later - perception off driving  3 hours later - light headed/ soreness 7 hours later - Every joint ached painfully 8 hours later - fever (high of 103.2) before Tylenol & Advil 19 hours later - slight fever 100.4 before Advil  21 hours later - feeling off/confused  25 hours later - achy / tired
Information has been received from a physician referring to an unspecified number of unspecified patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On unknown dates the patients were vaccinated with PNEUMOVAX23 (lot number, expiration dates, strength, dose and route were unknown). The patients concomitant medications were not reported. On unknown dates the patient had a "serious" injection site reaction to PNEUMOVAX23. The reporter stated that the injection site reactions lasted two to four weeks and the patients were treated with an unspecified steroid. The outcome of injection site reaction is unknown. The doctor treated the event to PNEUNOVAX23. Additional information has been requested.
Second COVID-19 vaccine given 1/28/2021 at 4:00pm.  Woke up next morning at 0500 with widespread intense itching and increased sinus congestions,  hives develop about 11:00am with increased shortness of breath and wheezing.  All signs and symptoms continued through today.  Improve with increased Zyrtec dose to 2 - 10 mg, Benadryl 50 mg Q4, and Albuterol inhaler 2 puffs Q4-Q6.  Improvement with medication regime.
pt stood up and got light headed and felt very faint. pharmacy tech had to hold her up. breathing rate changed.
rash after taking it; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (rash after taking it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (Dilantin).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash after taking it). At the time of the report, RASH (rash after taking it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information for the event was provided.
Pale, weak, headache shortly after vaccination.  Temp of 99.5 - evening 11/30/09.
Vaccine at 11:00 a.m. sore arm began at 3:00 p.m. then at 1:00 a.m. fever 99.7F, chills, nausea,  headache, body aches, fatigue,  and skin sensitivity. Chills, fever, and headache subsided by 4 a.m.  Fatigue, body aches, and skin sensitivity remained through the day.
Not Hasn't worked yet with no adverse event; Initial information received on 10-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient).  This case involved a patient of an unknown age and gender for whom not hasn't worked yet with no adverse event (Drug ineffective) was reported, after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number, expiry date and other dosing details were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient reported that not hadn't worked yet (Drug ineffective).  There will be no information available on the batch number for this case.
Fever of 99.5 from 5-7 hours after injection Fever of 101.1-101.3 from 7 hours after time of injection until 28 hours after time of injection (slowly went down after that time, fever completely gone by 36 hours after time of injection)